GOP’s Brown on looming device tax: Why?

Calling it a levy with no purpose or rationale, Sen. Scott Brown (R-Mass.) is seeking to revoke an excise tax set to be charged to medical device makers in 2013 as part of the healthcare reform law.

“A 2.3 percent tax just because?" Brown told MassDevice today after a speech at the Mass. Institute of Technology. "For some of these companies, that’s their entire net profit. That’s jobs, it’s R&D, it’s a whole list of other things. It’s not a necessary tax."

The Patient Protection and Affordable Care Act President Barack Obama signed into law last year contains a provision that would require device makers to fork over 2.3 percent of their gross U.S. revenues beginning in 2013. The levy is designed to help pay for healthcare reform and aims to raise about $20 billion over 10 years.

Brown, who campaigned against the tax as he sought the late Sen. Edward Kennedy’s seat in 2009, told us opposition to the tax is "gaining a lot of steam" inside the Beltway.

"It’s hard to say right now, but as with other bills I’ve had a tremendous amount of interest from everybody," Brown said when asked to handicap his bill’s chances of passing.

Should the bid fail, he added, "I’m open to all suggestions, because the bottom line is it’s being used just because. We can do better than that."

It’s not Brown’s first bid to overturn the tax. An amendment he introduced last year during the contentious debate over healthcare reform failed to pass muster, but Brown vowed not to give up the fight.

Yesterday, Boston Scientific Corp. (NYSE:BSX) CEO Ray Elliott praised Brown for his stand against the device tax.

“Repealing this onerous tax would help the US maintain global leadership in the development, manufacturing and export of medical technology,” Elliott said.

Other moves to repeal the tax are also afoot in Washington. Republicans in the House and Senate, including Sen. Orrin Hatch of Utah, introduced a trio of bills to shoot it down in late January. Brown was a co-signer of the Hatch bill.

His solo bill aims to repeal the tax without adding to the huge federal deficit by rescinding $39 billion in appropriated discretionary funds. Brown’s measure would give the director of the federal Office of Management and Budget final say over which discretionary funds to tap, excluding cash earmarked for the U.S. Dept. of Defense or the Dept. of Veterans Affairs.

"Sen. Scott Brown" image above by Mark Sardella acquired on Flickr.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply